Lv4
796 积分 2023-09-27 加入
PATH-10. PTEN homozygous deletion is a negative prognostic factor in Tumor Treating Fields-treated glioblastoma, IDH wildtype patients
6天前
已关闭
Tumor-Treating Fields: A Fourth Modality in Cancer Treatment
7天前
已完结
Wireless Electro‐Fenton Overcomes Tumor Electric Field Treatment Resistance
7天前
已完结
Identifying of biomarkers associated with gastric cancer based on 11 topological analysis methods of CytoHubba
8天前
已完结
Triple Oral Metronomic Chemotherapy Versus Chemotherapy of Physician Discretion After Failure of Platinum-Based Therapy in Advanced Head and Neck Cancer: A Phase III Randomized Study (METRO-CHASE Study)
8天前
已完结
Refining Postoperative Radiotherapy in Early-Stage Oral Squamous Cell Carcinoma: Impact of Perineural and Lymphovascular Invasion
14天前
已完结
Comparison of different target volume delineation strategies based on recurrence patterns in adjuvant radiotherapy for glioblastoma
1个月前
已完结
Influence of FLAIR inclusion on patterns-of-failure and outcomes in glioblastoma: results from the UNITED prospective adaptive radiotherapy trial
1个月前
已完结
Reduced Clinical Target Volume Margins in Glioblastoma: Exploratory Evidence Supporting Further Margin Reduction Independent of MGMT Status
1个月前
已完结
Reducing clinical target volume margins for multifocal glioblastoma: a multi-institutional analysis of patterns of recurrence and treatment response
1个月前
已完结
皖公网安备34019202002308
